[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.179.146. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
November 4, 1998

Simian Virus 40–Contaminated Polio Vaccine and Cancer Rates

Author Affiliations
 

Margaret A.WinkerMD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Senior EditorIndividualAuthor

JAMA. 1998;280(17):1481-1482. doi:10-1001/pubs.JAMA-ISSN-0098-7484-280-17-jbk1104

To the Editor.— In their report on contamination of poliovirus vaccine with simian virus 40 (SV40), Dr Strickler and colleagues1 mistakenly claim that "earlier studies of cancer risk following exposure to SV40-contaminated vaccine were generally limited by small sample size or short follow-up." I refute this suggestion and contend that my report,2 which they include in this group, neither was of limited sample size nor was it a short follow-up as arguably the others they refer to were.

First Page Preview View Large
First page PDF preview
First page PDF preview
×